| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/04/2012 | CN102078441B Pharmaceutical composition for treating hemiplegia |
| 01/04/2012 | CN102068530B Traditional Chinese medicine for preventing and treating vascular dementia |
| 01/04/2012 | CN102058841B Medicine for umbilicus external use for treating hypertension and preparation method thereof |
| 01/04/2012 | CN102049005B Chinese medicinal preparation for treating coronary heart diseases |
| 01/04/2012 | CN102028918B Application of Tibetan medicinal composition to preparation of medicament for treating cerebral circulation insufficiency |
| 01/04/2012 | CN101979040B Medicament for treating central serous chorioretinopathy |
| 01/04/2012 | CN101979020B Chinese medicinal preparation for treating high blood pressure |
| 01/04/2012 | CN101978979B Method for preparing refined celery extract |
| 01/04/2012 | CN101974012B Novel compound ethyl brevicate with pharmaceutical activity |
| 01/04/2012 | CN101974011B New compound methyl brevicate with medical activity |
| 01/04/2012 | CN101974010B New compound erigeron breviscapus acid with officinal activity |
| 01/04/2012 | CN101961339B Application of 23-HBA for preparing drug to reduce cardiotoxicity caused by adriamycin |
| 01/04/2012 | CN101953909B Medicament for treating cerebral infarction and preparation method thereof |
| 01/04/2012 | CN101953831B Buflomedil hydrochloride medicinal composition used for injection |
| 01/04/2012 | CN101953783B Preparation process of troxerutin injection |
| 01/04/2012 | CN101889978B Pharmaceutical composition containing vinpocetine, preparation method and application thereof |
| 01/04/2012 | CN101879230B Chinese medicinal jingnaoning capsules for treating mental retardation of cerebral infarction and preparation method |
| 01/04/2012 | CN101843604B Isosorbide dinitrate patch and preparation method thereof |
| 01/04/2012 | CN101829232B Preparation method of traditional Chinese medicine composition for treating thromboangiitis obliterans |
| 01/04/2012 | CN101780099B Meglumine adenosine cyclophosphate composite medicament |
| 01/04/2012 | CN101664505B Blood pressure lowering soup |
| 01/04/2012 | CN101658498B Freeze-drying manufactured product of cytidine triphosphate disodium and arginine and preparation method thereof |
| 01/04/2012 | CN101607070B Pharmaceutical composition for treating heart cerebrovascular disease |
| 01/04/2012 | CN101590071B Application of icariin in preparing medicaments for treating acute cerebral infarction |
| 01/04/2012 | CN101559203B Chinese medicament preparation for treating angina pectoris |
| 01/04/2012 | CN101541323B Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels |
| 01/04/2012 | CN101525314B Dihydropyridine calcium antagonist compound, preparation method and medicinal application thereof |
| 01/04/2012 | CN101524513B Health pillow drug core |
| 01/04/2012 | CN101524358B Medical application of psuedo-ginsenoside F11 |
| 01/04/2012 | CN101522693B Novel 5,7-disubstituted [1, 3] thiazolo [4, 5] pyrimidin-2 (3h)-amine deirvatives and their use in therapy |
| 01/04/2012 | CN101472565B Preparation method of granular formulation |
| 01/04/2012 | CN101461939B Angiotensin converting enzyme inhibitor and preparation thereof |
| 01/04/2012 | CN101445544B Method for preparing ginsenoside Rb<1> |
| 01/04/2012 | CN101439041B Chinese medicine granule containing breviscapine and preparation method thereof |
| 01/04/2012 | CN101347434B Medicament composition containing renin inhibitor and acidum folicum compound and uses thereof |
| 01/04/2012 | CN101347422B Uses of salvianolic acid A in preventing and/or treating diabetes and complication |
| 01/04/2012 | CN101313900B Hydroxy fatty acid oligomer and application in regulating calcium ion concentration in cell |
| 01/04/2012 | CN101289444B Pyrimidine derivate and medicinal use thereof |
| 01/04/2012 | CN101288667B Application of chrysanthenone in preparing drug for treating coronary heat disease |
| 01/04/2012 | CN101204522B Pharmaceutical capsules for blood deficiency hypertension |
| 01/04/2012 | CN101199678B Chinese medicine agent for treating CHF heart failure merger angina and preparing method thereof |
| 01/04/2012 | CN101085021B Medicinal composition containing safflower and radix astragali, preparation method and preparation |
| 01/04/2012 | CN101085018B Traditional Chinese medicinal composition containing red sage root, notoginseng, radix astragali and borneol or storax and its preparation |
| 01/03/2012 | US8088906 FAD4, FAD5, FAD5-2, and FAD6, novel fatty acid desaturase family members and uses thereof |
| 01/03/2012 | US8088893 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 01/03/2012 | US8088886 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 01/03/2012 | US8088827 Use of irbesartan for the preparation of medicinal products that are useful for treating pulmonary hypertension |
| 01/03/2012 | US8088825 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/03/2012 | US8088780 5,7-disubstituted thiazolo[4,5-D]pyrimidines for the selective inhibition of chemokine receptors |
| 01/03/2012 | US8088768 Protein kinase and phosphatase inhibitors |
| 01/03/2012 | US8088371 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; coat suture, stent, screw, plate implants with plasma |
| 01/03/2012 | US8088157 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
| 01/03/2012 | CA2632556C Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 01/03/2012 | CA2528160C Use of 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl) piperazine for neuronal regeneration and functional recovery |
| 01/03/2012 | CA2524525C Novel pyridopyrazines and use thereof as kinase modulators |
| 01/03/2012 | CA2488565C Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 01/03/2012 | CA2480423C Truncated 24 kda basic fibroblast growth factor |
| 01/03/2012 | CA2468910C Use of 4-oxobutanoic acid derivatives in the treatment of inflammation |
| 01/03/2012 | CA2457719C Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 01/03/2012 | CA2456717C Phenyl derivatives as factor xa inhibitors |
| 01/03/2012 | CA2455972C N6-benzyl and phenyl substituted adenines and their use as cosmetics, pharmaceutical preparations and plant growth regulators |
| 01/03/2012 | CA2446837C Stable high-concentration injection containing pyrazolone derivative |
| 01/03/2012 | CA2395684C Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/03/2012 | CA2366433C Staphylococcus antigen and vaccine |
| 01/03/2012 | CA2242414C Anti-cd18 antibodies for use against stroke |
| 01/03/2012 | CA2227265C Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis |
| 01/03/2012 | CA2224468C P53 protein variants and therapeutical uses thereof |
| 01/03/2012 | CA2210998C Inhibition of neovascularization using vegf-specific oligonucleotides |
| 12/29/2011 | WO2011163669A2 Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones |
| 12/29/2011 | WO2011163531A2 Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases |
| 12/29/2011 | WO2011162835A1 Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors |
| 12/29/2011 | WO2011162562A2 [6+5] fused bicycles as a thrombin antagonist, process for preparation thereof and pharmaceutical compositions containing the bicycles |
| 12/29/2011 | WO2011162390A1 Sustained-release therapeutic agent for hypertension and renal dysfunction |
| 12/29/2011 | WO2011162320A1 Combination of egcg or methylated egcg and a pde inhibitor |
| 12/29/2011 | WO2011162300A1 Crystal of fused pyridine compound salt |
| 12/29/2011 | WO2011162267A1 Novel thiophenecarboxamide derivatives and use thereof as medicine |
| 12/29/2011 | WO2011161537A2 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof |
| 12/29/2011 | WO2011161159A1 Heterocyclic compounds, their preparation and their therapeutic application |
| 12/29/2011 | WO2011161123A2 Multilayer pharmaceutical tablet comprising telmisartan and a diuretic |
| 12/29/2011 | WO2011160845A2 Oxidized phospholipids and lipoproteins, and antibodies thereto, as biomarkers of inflammatory conditions and methods of treatment |
| 12/29/2011 | WO2011160632A1 Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors |
| 12/29/2011 | WO2011160597A1 Furocoumarin compounds with antihypertensive activity and preparation methods thereof |
| 12/29/2011 | WO2011160444A1 Pharmaceutical composition comprising vanadium and its use |
| 12/29/2011 | WO2011160443A1 Pharmaceutical composition comprising vanadium and its use |
| 12/29/2011 | WO2011160434A1 Preparing process and quality controlling method for an compound injection |
| 12/29/2011 | WO2011160396A1 Method for preparation of ranolazine |
| 12/29/2011 | WO2011160189A1 METHOD OF SCREENING FOR INHIBITORS OF sPLA2-IIA |
| 12/29/2011 | WO2011135581A8 Pharmaceutical compositions of dronedarone |
| 12/29/2011 | WO2011120040A3 Thrombin inhibiting compositions |
| 12/29/2011 | WO2011112840A3 Water-soluble phytosterol derivatives for reducing cholesterol and preparation thereof |
| 12/29/2011 | WO2011091366A3 Methods of treating or preventing periodontitis and diseases associated with periodontitis |
| 12/29/2011 | WO2011089168A3 Special composition for the use thereof as a drug |
| 12/29/2011 | WO2010129138A3 Phosphorylated and phosphonated pyrone analogs for therapeutic treatment |
| 12/29/2011 | US20110319499 Methods for the Detection of Advanced Glycation Endproducts and Markers for Disease |
| 12/29/2011 | US20110319496 Process for the preparation of ajoene |
| 12/29/2011 | US20110319494 Substituted Aryl-Indole Compounds and Their Kynurenine/Kynuramine-Like Metabolites As Therapeutic Agents |
| 12/29/2011 | US20110319482 Novel treatments |
| 12/29/2011 | US20110319479 Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia |
| 12/29/2011 | US20110319478 Compositions to Treat Cardiac Pacing Conditions |
| 12/29/2011 | US20110319476 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf |